BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24918581)

  • 1. QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2.
    Lu W; Feng F; Xu J; Lu X; Wang S; Wang L; Lu H; Wei M; Yang G; Wang L; Lu Z; Liu Y; Lei X
    Cancer Biol Ther; 2014 Sep; 15(9):1174-84. PubMed ID: 24918581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB-regulated miR-155, via repression of QKI, contributes to the acquisition of CSC-like phenotype during the neoplastic transformation of hepatic cells induced by arsenite.
    Chen C; Luo F; Yang Q; Wang D; Yang P; Xue J; Dai X; Liu X; Xu H; Lu J; Zhang A; Liu Q
    Mol Carcinog; 2018 Apr; 57(4):483-493. PubMed ID: 29240254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfection of T-Box Transcription Factor
    Akimoto N; Nakamura K; Hijioka H; Kume K; Matsumura Y; Sugiura T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
    Bourguignon LY; Wong G; Earle C; Chen L
    J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell division patterns and chromosomal segregation defects in oral cancer stem cells.
    Kaseb HO; Lewis DW; Saunders WS; Gollin SM
    Genes Chromosomes Cancer; 2016 Sep; 55(9):694-709. PubMed ID: 27123539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
    Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
    Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA
    Zhao X; Wu J; Li Y; Ye F; Wang C
    Bioengineered; 2021 Dec; 12(1):8698-8708. PubMed ID: 34697986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.
    Kim M; Jang K; Miller P; Picon-Ruiz M; Yeasky TM; El-Ashry D; Slingerland JM
    Oncogene; 2017 Sep; 36(36):5199-5211. PubMed ID: 28504716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer.
    Singh S; Trevino J; Bora-Singhal N; Coppola D; Haura E; Altiok S; Chellappan SP
    Mol Cancer; 2012 Sep; 11():73. PubMed ID: 23009336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
    Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells.
    Mukohyama J; Isobe T; Hu Q; Hayashi T; Watanabe T; Maeda M; Yanagi H; Qian X; Yamashita K; Minami H; Mimori K; Sahoo D; Kakeji Y; Suzuki A; Dalerba P; Shimono Y
    Cancer Res; 2019 Oct; 79(20):5151-5158. PubMed ID: 31416845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 13. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
    Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
    Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional repressor GATA binding 1-mediated repression of SRY-box 2 expression suppresses cancer stem cell functions and tumor initiation.
    Gong X; Liu W; Wu L; Ma Z; Wang Y; Yu S; Zhang J; Xie H; Wei G; Ma F; Lu L; Chen L
    J Biol Chem; 2018 Nov; 293(48):18646-18654. PubMed ID: 30315105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells.
    Chou MY; Hu FW; Yu CH; Yu CC
    Oral Oncol; 2015 Jan; 51(1):31-9. PubMed ID: 25456004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
    Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
    Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
    Vazquez-Martin A; Cufí S; López-Bonet E; Corominas-Faja B; Cuyàs E; Vellon L; Iglesias JM; Leis O; Martín AG; Menendez JA
    Cell Cycle; 2013 Nov; 12(22):3471-7. PubMed ID: 24107627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells.
    Shimoda M; Sugiura T; Imajyo I; Ishii K; Chigita S; Seki K; Kobayashi Y; Shirasuna K
    BMC Cancer; 2012 Aug; 12():377. PubMed ID: 22931165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-155 promotes the proliferation and invasion abilities of colon cancer cells by targeting quaking.
    He B; Gao SQ; Huang LD; Huang YH; Zhang QY; Zhou MT; Shi HQ; Song QT; Shan YF
    Mol Med Rep; 2015 Mar; 11(3):2355-9. PubMed ID: 25420938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.